New capsule aims to ease IBS-D symptoms without drugs
NCT ID NCT06681012
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether Gelsectan, a capsule made from plant-based ingredients, can reduce abdominal pain and improve stool consistency in people with diarrhea-predominant irritable bowel syndrome (IBS-D). About 330 adults will take either Gelsectan or a placebo twice daily for two months. The goal is to see if this device can offer a safe, non-drug way to manage symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Gelsectan (a medical device containing xyloglucan, pea protein, grape seed extract, and xylo-oligosaccharides)
- What this could lead to
- If it works, this could provide a new, non-drug option to help manage IBS-D symptoms like abdominal pain and diarrhea, improving quality of life.
- What could go wrong
- This is a mid-stage study, so results may not confirm earlier findings. The effect may be modest, and not everyone will benefit. As a medical device, it is generally considered low-risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME (IBS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AOU Federico II di Napoli
RECRUITINGNaples, 80131, Italy
-
Azienda Ospedale Università Padova
RECRUITINGPadova, 35128, Italy
-
Azienda Ospedaliero Universitaria Pisana (AOUP)
RECRUITINGPisa, 56124, Italy
-
CHU de Rouen
RECRUITINGRouen, 76000, France
-
Fondazione IRCCS Policlinico San Matteo
RECRUITINGPavia, 27100, Italy
-
Hospital Universitario Ramón y Cajal
RECRUITINGMadrid, 28034, Spain
-
Hospital Universitario Vall d´Hebron
RECRUITINGBarcelona, 08035, Spain
-
Hôpital Avicenne
RECRUITINGBobigny, 93000, France
-
IRCCS Azienda Ospedaliero Universitaria di Bologna Policlinico Sant'Orsola
RECRUITINGBologna, BO, 40138, Italy
-
IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation
RECRUITINGMilan, 20122, Italy
-
S. Andrea University Hospital
RECRUITINGRoma, 00189, Italy
-
University Hospitals Leuven (UZ Leuven)
RECRUITINGLeuven, 3000, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Dual-Action supplement tame irritable bowel syndrome?
- Could an Anti-Inflammatory diet designed for Crohn's disease also tame IBS?
- Scientists hunt for the exact FODMAPs that trigger IBS pain
- Gut-Brain connection in IBS: scientists hunt for clues to anxiety and depression
- Could a nerve pain drug soothe IBS symptoms?
- Massive new registry aims to crack the code on mysterious gut disorders